Matches in Wikidata for { <http://www.wikidata.org/entity/Q93185137> ?p ?o ?g. }
Showing items 1 to 56 of
56
with 100 items per page.
- Q93185137 description "article scientifique publié en 2020" @default.
- Q93185137 description "artículu científicu espublizáu n'abril de 2020" @default.
- Q93185137 description "bài báo khoa học" @default.
- Q93185137 description "im April 2020 veröffentlichter wissenschaftlicher Artikel" @default.
- Q93185137 description "scientific article published on 19 April 2020" @default.
- Q93185137 description "wetenschappelijk artikel" @default.
- Q93185137 description "наукова стаття, опублікована 19 квітня 2020" @default.
- Q93185137 name "Public Adverse Event Data Insights into the Safety of Pembrolizumab in Melanoma Patients" @default.
- Q93185137 name "Public Adverse Event Data Insights into the Safety of Pembrolizumab in Melanoma Patients" @default.
- Q93185137 type Item @default.
- Q93185137 label "Public Adverse Event Data Insights into the Safety of Pembrolizumab in Melanoma Patients" @default.
- Q93185137 label "Public Adverse Event Data Insights into the Safety of Pembrolizumab in Melanoma Patients" @default.
- Q93185137 prefLabel "Public Adverse Event Data Insights into the Safety of Pembrolizumab in Melanoma Patients" @default.
- Q93185137 prefLabel "Public Adverse Event Data Insights into the Safety of Pembrolizumab in Melanoma Patients" @default.
- Q93185137 P1433 Q93185137-2266D2DF-280F-4B60-9B9D-D3BCE1B2F306 @default.
- Q93185137 P1476 Q93185137-4C6217FA-8DF1-4795-9708-97479043034E @default.
- Q93185137 P2093 Q93185137-062F0ED0-82C7-4972-BF5A-737AAFF731E7 @default.
- Q93185137 P2093 Q93185137-5258E8C6-5C83-45CE-B840-EBE68F1EF99C @default.
- Q93185137 P2093 Q93185137-5D3ED27B-5005-481F-821E-57659B6A1DA7 @default.
- Q93185137 P2093 Q93185137-5DEE084D-57D6-4567-814A-506779FE1428 @default.
- Q93185137 P2093 Q93185137-7911A383-D9F1-45D3-9C86-BD52AFC0AB00 @default.
- Q93185137 P2093 Q93185137-A70A1B7D-E8EC-4084-94B6-50174EB9AE46 @default.
- Q93185137 P2093 Q93185137-AA1562A3-BFCF-4EE1-A768-D16F4C862D52 @default.
- Q93185137 P275 Q93185137-e182ff43-e6b0-489e-aa1b-4b84ba6c5a35 @default.
- Q93185137 P31 Q93185137-A68D94DF-E900-4F35-9BB0-C15947682154 @default.
- Q93185137 P356 Q93185137-55265D46-97C3-44A6-9362-D79E4AD82396 @default.
- Q93185137 P433 Q93185137-17FA01D4-9790-48DF-A258-6FF8A1B49F18 @default.
- Q93185137 P478 Q93185137-0F4FEE84-B8E1-48DF-B41D-D76F2FDF6737 @default.
- Q93185137 P50 Q93185137-46DCF63E-A32A-4D34-A1E3-D5700CC76001 @default.
- Q93185137 P577 Q93185137-7640C77A-D5F3-4B07-B511-E40F13D49523 @default.
- Q93185137 P6216 Q93185137-c3192851-c9c6-4c7a-a619-04f47b2bb5fe @default.
- Q93185137 P698 Q93185137-0BE26CC8-FDEE-45B9-898D-E586715C95D0 @default.
- Q93185137 P921 Q93185137-A8920D6C-7A13-476B-A393-7557EC31A97E @default.
- Q93185137 P932 Q93185137-DE726D12-43B6-4E8D-9F52-3769E3894209 @default.
- Q93185137 P356 CANCERS12041008 @default.
- Q93185137 P698 32325840 @default.
- Q93185137 P1433 Q27722963 @default.
- Q93185137 P1476 "Public Adverse Event Data Insights into the Safety of Pembrolizumab in Melanoma Patients" @default.
- Q93185137 P2093 "Anja Doerks" @default.
- Q93185137 P2093 "Anne Schaefer" @default.
- Q93185137 P2093 "Anne-Sophie Kratz" @default.
- Q93185137 P2093 "Christian Meisel" @default.
- Q93185137 P2093 "Christos Sachpekidis" @default.
- Q93185137 P2093 "David B Jackson" @default.
- Q93185137 P2093 "Francesca Diella" @default.
- Q93185137 P275 Q20007257 @default.
- Q93185137 P31 Q13442814 @default.
- Q93185137 P356 "10.3390/CANCERS12041008" @default.
- Q93185137 P433 "4" @default.
- Q93185137 P478 "12" @default.
- Q93185137 P50 Q57209867 @default.
- Q93185137 P577 "2020-04-19T00:00:00Z" @default.
- Q93185137 P6216 Q50423863 @default.
- Q93185137 P698 "32325840" @default.
- Q93185137 P921 Q13896859 @default.
- Q93185137 P932 "7226447" @default.